本文轉載至原廠電子報: Reaction biology https://www.reactionbiology.com/
原廠電子報
|
Reutilizing Kinase inhibitors: Drug screening identifies key kinase inhibitors exhibiting anti-SARS-CoV-2 activity.
|
|
|
The ability of several small-molecule kinase inhibitors to modulate immune responses, as well as potentially block various stages in the SARS-CoV-2 life cycle, suggests they may have an important role in the emerging therapeutic arsenal. Screening kinase inhibitors against infected cell lines will not only help us discover alternative SARS-CoV-2 treatments but also help us understand the cell biology of the SARS-CoV-2.
Read more about recent findings on repurposing kinase inhibitors to fight SARS-CoV-2 in our newest blog.
|
|
|
|
|
|